Beta Drugs Limited — Lenalidomide Exporter Profile
Indian Pharmaceutical Exporter · #12 for Lenalidomide · $110.3K export value · DGFT Verified
Beta Drugs Limited is the #12 Indian exporter of Lenalidomide with $110.3K in export value and 66 verified shipments. Beta Drugs Limited holds a 0.0% market share in Lenalidomide exports across 10 countries. The company exports 17 pharmaceutical products worth $7.8M across 5 therapeutic categories.
Beta Drugs Limited — Lenalidomide Export Profile: Buyers & Destinations
Where Does Beta Drugs Limited Export Lenalidomide?
| Country | Value | Shipments | Share |
|---|---|---|---|
| NEPAL | $40.0K | 18 | 36.2% |
| LEBANON | $28.2K | 4 | 25.6% |
| VENEZUELA | $25.8K | 12 | 23.4% |
| BRAZIL | $5.8K | 12 | 5.2% |
| ZIMBABWE | $5.0K | 1 | 4.5% |
| ETHIOPIA | $2.9K | 2 | 2.6% |
| MOLDOVA,REPUBLIC OF | $1.8K | 1 | 1.7% |
| MAURITIUS | $781 | 4 | 0.7% |
| ALGERIA | $29 | 10 | 0.0% |
| KENYA | $8 | 2 | 0.0% |
Beta Drugs Limited exports Lenalidomide to 10 countries. The largest destination is NEPAL accounting for 36.2% of Beta Drugs Limited's Lenalidomide shipments, followed by LEBANON (25.6%) and VENEZUELA (23.4%). These destinations reflect Beta Drugs Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Lenalidomide from Beta Drugs Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| TO THE ORDER OF | NEPAL | $23.5K | 10 |
| GLOBAL CARE PHARMA CA | VENEZUELA | $16.6K | 9 |
| EXPTRANS GMBH SARL | LEBANON | $14.2K | 2 |
| EXPTRANS GMBH S.A.R.L. | LEBANON | $14.0K | 2 |
| SIJAL PHARMA PVT LTD | NEPAL | $11.9K | 6 |
| GLOBAL CARE PHARMA,CA | VENEZUELA | $8.5K | 2 |
| SYNVIA LABORATORIOS E TOXICOLOGIA | BRAZIL | $5.8K | 12 |
| HARARE ONCOLOGY PHARMACIES | ZIMBABWE | $5.0K | 1 |
| MACHHAPUCHCHHRE BANK LIMITED, | NEPAL | $3.7K | 2 |
| SIJAL PHARMA PVT.LTD. | NEPAL | $2.4K | 1 |
Beta Drugs Limited supplies Lenalidomide to 16 buyers globally. The largest buyer is TO THE ORDER OF (NEPAL), followed by GLOBAL CARE PHARMA CA (VENEZUELA) and EXPTRANS GMBH SARL (LEBANON). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Lenalidomide Export Value and How Much Does Beta Drugs Limited Contribute?
India exported $30.4M worth of Lenalidomide through 2,724 shipments from 237 suppliers to 122 countries, serving 557 buyers globally. Beta Drugs Limited contributes $110.3K to this total, accounting for 0.0% of India's Lenalidomide exports. Beta Drugs Limited ships Lenalidomide to 10 countries through 16 buyers.
What Is the Average Shipment Value for Beta Drugs Limited's Lenalidomide Exports?
Beta Drugs Limited's average Lenalidomide shipment value is $1.7K per consignment, based on 66 shipments totaling $110.3K. The largest destination is NEPAL (36.2% of Beta Drugs Limited's Lenalidomide exports).
How Does Beta Drugs Limited Compare to Other Indian Lenalidomide Exporters?
Beta Drugs Limited ranks #12 among 237 Indian Lenalidomide exporters with a 0.0% market share. The top 3 exporters are EUGIA PHARMA SPECIALITIES LIMITED ($9.4M), RELIANCE LIFE SCIENCES PRIVATE LIMITED ($8.3M), SUN PHARMACEUTICAL INDUSTRIES LIMITED ($7.2M). Beta Drugs Limited processed 66 shipments to 10 destination countries.
What Lenalidomide Formulations Does Beta Drugs Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| ADLINOD 10MG (LENALIDOMIDE 10MG CAPSULES | $10.6K | 4 |
| ADLINOD 25 MG LENALIDOMIDE CAPSULES 25 MG BATCH: BC23218A MFD: SEP-23 EXP: AUG-25 | $9.2K | 1 |
| ADLINOD 25MG (LENALIDOMIDE 25MG CAPSULES | $9.0K | 1 |
| LENOLIDOMIDA 10MG LENALIDOMIDE CAPSULES10MG BATCH: BC23246C MFD: OCT-23 EXP: SEP-25 | $8.4K | 3 |
| ADLINOD 25 MG LENALIDOMIDE CAPSULES IP( 25 MG) BATCH: BC24412B, MFD: DEC-24, EXP: NOV-26 | $6.9K | 2 |
| LENALIDOMIDA 25MG LENALIDOMIDE CAPSULE (25MG) BATCH: BC24018C, MFD: JAN-24, EXP:DEC-25 | $5.7K | 1 |
| ADLINOD 10 MG LENALIDOMIDE CAPSULES 10 MG BATCH: BC23219A MFD: SEP-23 EXP: AUG-25 | $5.1K | 1 |
| REVLICAN 25 MG LENALIDOMIDE CAPSULE (25MG) BATCH: BC25023A, MFD: JAN-25, EXP: DEC-26 | $5.0K | 1 |
| ADLINOD 10 MG LENALIDOMIDE CAPSULES ( 10MG) BATCH: BC24411C, MFD: DEC-24, EXP:NOV-26 | $4.8K | 2 |
| LENALIDOCIDA 5MG LENALIDOMIDE CAPSULES 5MG BATCH: BC23137B MFD: JUL-23 EXP: JUN-25 | $4.5K | 3 |
Beta Drugs Limited exports 43 distinct Lenalidomide formulations including tablets, capsules, syrups, and combination drugs. The top formulation is ADLINOD 10MG (LENALIDOMIDE 10MG CAPSULES with 4 shipments worth $10.6K.
How Does Beta Drugs Limited Compare to Nearest Lenalidomide Exporters?
Exporters ranked immediately above and below #12 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 10 | RMPL PHARMA LLP | $145.7K | 82 | 10 | $1.8K |
| 11 | MYLAN LABORATORIES LIMITED | $133.2K | 20 | 6 | $6.7K |
| 12 | BETA DRUGS LIMITED ★ | $110.3K | 66 | 10 | $1.7K |
| 13 | CAPLIN POINT LABORATORIES LIMITED | $107.3K | 4 | 1 | $26.8K |
| 14 | 3S PHARMACEUTICALS INDIA PRIVATE LIMITED | $88.4K | 56 | 6 | $1.6K |
Beta Drugs Limited ranks #12 among 237 Indian Lenalidomide exporters. Average shipment value of $1.7K compared to the market average of $128.1K. The closest competitors by value are RMPL PHARMA LLP and MYLAN LABORATORIES LIMITED.
Which Indian Ports Ship Lenalidomide Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 740 | 27.2% |
| SAHAR AIR | 688 | 25.3% |
| DELHI AIR CARGO ACC (INDEL4) | 187 | 6.9% |
| Bombay Air | 180 | 6.6% |
| DELHI AIR | 140 | 5.1% |
| Bombay Air Cargo | 88 | 3.2% |
| HYDERABAD ACC (INHYD4) | 78 | 2.9% |
| HYDERABAD AIR | 68 | 2.5% |
What Other Advanced Oncology Products Does Beta Drugs Limited Export?
Beta Drugs Limited also exports these advanced oncology products. Each links to the detailed product page.
About Beta Drugs Limited
Beta Drugs Limited exports 17 products worth $7.8M. Beyond Lenalidomide, top products include Linagliptin, Sitagliptin, Carboplatin, Capecitabine, Mercaptopurine. View the complete Beta Drugs Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Lenalidomide — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Lenalidomide shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Beta Drugs Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 66 individual customs records matching Beta Drugs Limited exporting Lenalidomide, covering 43 formulations to 10 countries via 16 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 122+ countries, 557+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Lenalidomide Export Data from Beta Drugs Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Beta Drugs Limited's Lenalidomide exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Beta Drugs Limited
Full Company Profile →
17 products · $7.8M total trade · 5 categories
Lenalidomide Stats
Company Overview
Top Products by Beta Drugs Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Beta Drugs Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Lenalidomide. For current shipment-level data, contact TransData Nexus.